Artificial Intelligence in Drug Discovery
A podcast by Simon Smith
12 Episoade
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Publicat: 07.08.2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Publicat: 07.08.2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Publicat: 30.07.2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Publicat: 26.07.2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Publicat: 18.07.2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Publicat: 10.07.2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Publicat: 28.06.2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Publicat: 20.06.2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Publicat: 11.06.2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Publicat: 29.05.2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Publicat: 22.05.2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Publicat: 14.05.2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
